Human Papillomavirus (HPV) Prevalence and E6 Protein Expression in Gastric Cancer Tissue Samples Compared with Non-malignant and Control Groups in East Azerbaijan Province, Iran, 2021

Jafari-Sales, Abolfazl; Shariat, Afsoon; Bannazadeh-Baghi, Hossein; Baradaran, Behzad; Jafari, Behboud

doi:10.30699/ijmm.17.1.58

year 17, Issue 1 (January - February 2023) Iran J Med Microbiol 2023, 17(1): 58-65 | Back to browse issues page

‎ 10.30699/ijmm.17.1.58

Mendeley

Zotero

RefWorks

Jafari-Sales A, Shariat A, Bannazadeh-Baghi H, Baradaran B, Jafari B. Human Papillomavirus (HPV) Prevalence and E6 Protein Expression in Gastric Cancer Tissue Samples Compared with Non-malignant and Control Groups in East Azerbaijan Province, Iran, 2021. Iran J Med Microbiol 2023; 17 (1) :58-65
URL: http://ijmm.ir/article-1-1782-en.html

Human Papillomavirus (HPV) Prevalence and E6 Protein Expression in Gastric Cancer Tissue Samples Compared with Non-malignant and Control Groups in East Azerbaijan Province, Iran, 2021

Abolfazl Jafari-Sales¹

, Afsoon Shariat

², Hossein Bannazadeh-Baghi³

, Behzad Baradaran⁴

, Behboud Jafari⁵

1- Department of Microbiology, School of Basic Sciences, Kazerun Branch, Islamic Azad University, Kazerun, Iran
2- Department of Microbiology, School of Basic Sciences, Kazerun Branch, Islamic Azad University, Kazerun, Iran , afsoonsh1980@yahoo.com
3- Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
4- Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
5- Department of Microbiology, School of Basic Sciences, Ahar Branch, Islamic Azad University, Ahar, Iran

Abstract: (2880 Views)

Background and Aim: Gastric cancer (GC) is a major health problem worldwide. Several studies have shown the virus's role in cancer pathogenesis. Therefore, the aim of this study was to evaluate the presence of human papillomavirus (HPV) in GC by immunohistochemistry (IHC) and polymerase chain reaction (PCR) in hospitals in the East Azerbaijan province, Iran.
Materials and Methods: In this descriptive cross-sectional study, 100 tissue samples of paraffin-embedded, including GC (50 samples), benign gastric hyperplasia (25 samples), and a control group (25 samples) were collected from the archives of laboratories in East Azerbaijan province from April to October 2021. The IHC and PCR were used to detect the HPV virus. SPSS software version 22 and t-test and Chi-Square statistical tests were used for data analysis.
Results: 8 out of 50 cancer samples were HPV positive by IHC and PCR. HPV-positive samples had a mean age of 62.87 ± 9.67 and a higher Gleason score. Men had the highest number of HPV-positive samples compared to women (5 samples vs. 3 samples). However, no viral genomes were observed in non-malignant and control samples. There was a significant relationship between HPV infection and GC (P=0.03).
Conclusion: According to the present study's findings, the presence of HPV infection in GC plays an important role in the development of GC in the hospitals of East Azerbaijan province. Also, the results showed that PCR and IHC are both more sensitive and reliable in detecting HPV because the results of both IHC and PCR were the same. Hence IHC method can be used as an alternative to the PCR method to detect HPV oncoproteins.

Keywords: E6 protein, Gastric cancer, Human papillomavirus, Immunohistochemistry, PCR

Full-Text [PDF 558 kb] (1681 Downloads) | | Full-Text (HTML) (727 Views)

Type of Study: Original Research Article | Subject: Medical Virology
Received: 2022/06/13 | Accepted: 2022/09/11 | ePublished: 2023/01/20

References

1. Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179-203. [DOI:10.1007/s10555-020-09925-3] [PMID] [PMCID]

2. Hamilton SR. World Health Organization classification of tumours. Pathology genetics of tumours of the digestive system 2000 [

3. Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009;12(6):576-83.

4. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: Results of a population-based Cancer Registry from Iran. Int J Cancer. 2003;107(1):113-8. [DOI:10.1002/ijc.11359] [PMID]

5. Rahimi F, Heidari M. Time Trend Analysis of Stomach Cancer Incidence in the West of Iran. Health Dev J 2012;1(2).

6. Enayatrad M, Salehiniya H. Trends in Gastric Cancer Incidence in Iran. J Mazand Univ Med Sci. 2014;24(114):8-16.

7. Camargo MC, Kim W-H, Chiaravalli AM, Kim K-M, Corvalan AH, Matsuo K, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2014;63(2):236. [DOI:10.1136/gutjnl-2013-304531] [PMID] [PMCID]

8. McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim Biophys Acta Mol Basis Dis. 2008;1782(3):127-50. [DOI:10.1016/j.bbadis.2007.12.005] [PMID] [PMCID]

9. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 2010;10(12):878-89. [DOI:10.1038/nrc2961] [PMID] [PMCID]

10. Gervaz P, Hirschel B, Morel P. Molecular biology of squamous cell carcinoma of the anus. Br J Surg. 2006;93(5):531-8. [DOI:10.1002/bjs.5376] [PMID]

11. Śnietura M, Jaworska M, Pigłowski W, Goraj-Zając A, Woźniak G, Lange D. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx. Pol J Pathol. 2010;61(3).

12. Snietura M, Piglowski W, Jaworska M, Mucha-Malecka A, Wozniak G, Lange D, et al. Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer. Eur Arch Oto-Rhino-L. 2011;268(5):721-6. [DOI:10.1007/s00405-010-1396-7] [PMID] [PMCID]

13. Shokouh MR, Safaei A, Moattari A, Sarvari J. Association of Human Papilloma Virus and Epstein-Barr Virus with Ovarian Cancer in Shiraz, Southwestern Iran. Iran J Pathol. 2020;15(4):292-8. [DOI:10.30699/ijp.2020.119681.2306] [PMID] [PMCID]

14. Mostafapour Badpey M, Zaker Bostanabad S, Rahimi MK. Study of Abundance and Genotyping of Human Papillomavirus in Samples of Patients Suspected to Cervical Cancer Referred to Masoud Labratory in Tehran. Iran J Med Microbiol. 2018;12 (5):348-56. [DOI:10.30699/ijmm.12.5.348]

15. Salehpour M, Tayyebi Meibodi N, Teimourpour R, Ghorani-Azam A, Sepahi S, Rostami S, et al. Frequency of Human Papillomavirus Genotypes 6, 11, 16, 18 And 31 in Paraffin-Embedded Tissue Samples of Invasive Breast Carcinoma, North- East of Iran. Iran J Pathol. 2015;10(3):192-8.

16. Fakhraei F, Haghshenas MR. Human papillomaviruses and cancer. J Mazandaran Univ Med Sci. 2013;23(98):340-60.

17. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-9. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F [DOI:10.1002/(SICI)1096-9896(199909)189:13.0.CO;2-F]

18. Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 2014;26:13-21. [DOI:10.1016/j.semcancer.2013.11.002] [PMID]

19. Hardefeldt HA, Cox MR, Eslick GD. Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a meta analysis. Epidemiol Infect. 2014;142(6):1119-37. [DOI:10.1017/S0950268814000016] [PMID] [PMCID]

20. Neshat S, Daneii P, Neshat N, Raeisi S, Raeisi S, Malakooti SM, et al. Concerning the Prevalence of HPV Genotypes and the Evaluation of Pap smear Results in Iranian Population: An Update. Iran J Pathol. 2021;16(3):346-7. [DOI:10.30699/ijp.2021.523796.2578] [PMID] [PMCID]

21. Emadian O, Naghshvar F, Rafiei AR, Maleki E, Torabizadeh J, Rezaei F. Correlation of Human Papillomavirus Infection with Esophageal Squamous Cell Carcinoma. Babol Univ Med Sci. 2011;13(4):54-9.

22. Karbasi A, Borhani N, Daliri K, Kazemi B, Manoochehri M. Downregulation of external death receptor genes FAS and DR5 in colorectal cancer samples positive for human papillomavirus infection. Pathol Res Pract. 2015;211(6):444-8. [DOI:10.1016/j.prp.2015.02.001] [PMID]

23. Noori S, Monabati A, Ghaderi A. The prevalence of human papilloma virus in esophageal squamous cell carcinoma. Iran J Med Sci. 2012;37(2):126-33.

24. Zeng ZM, Luo FF, Zou LX, He RQ, Pan DH, Chen X, et al. Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases. Onco Targets Ther. 2016;9:7105-14. [DOI:10.2147/OTT.S115053] [PMID] [PMCID]

25. Cândido AC, de Lima Filho JL, Martins DB, Mendes CM, Vieira JR, Ferraz AA. Association of human papillomavirus genomic sequences by polymerase chain reaction in gastric carcinomas in Brazil. Anal Quant Cytopathol Histpathol. 2013;35(1):1-6.

26. Snietura M, Waniczek D, Piglowski W, Kopec A, Nowakowska-Zajdel E, Lorenc Z, et al. Potential role of human papilloma virus in the pathogenesis of gastric cancer. World J Gastroenterol. 2014;20(21):6632-7. [DOI:10.3748/wjg.v20.i21.6632] [PMID] [PMCID]

27. Shariat A, Arzani P. Studying the Association Between Human Papillomavirus and Prostate Cancer by Immunohistochemistry and PCR Techniques in Ahvaz Hospitals. Jundishapur J Microbiol. 2020;19:425-34.

28. Ghaffar M, Li J, Zhang L, Khodahemmati S, Wang M, Wang Y, et al. Water Carcinogenicity and Prevalence of HPV Infection in Esophageal Cancer Patients in Huaihe River Basin, China. Gastroenterol Res Pract. 2018;2018:2028986. [DOI:10.1155/2018/2028986] [PMID] [PMCID]

29. Masoumalinejad Z, Zinatizadeh MR. Molecular Identification of Human Papilloma Virus in Tissue Samples from Patients with Cervical Cancer by Multiplex PCR Method. Health Res J. 2018;3(1):29-35. [DOI:10.29252/hrjbaq.3.1.29]

30. Zhu S, Sun P, Zhang Y, Yan L, Luo B. Expression of c-myc and PCNA in EpsteinBarr virus-associated gastric carcinoma. Exp Ther Med. 2013;5(4):1030-4. [DOI:10.3892/etm.2013.972] [PMID] [PMCID]

31. Snietura M, Waniczek D, Nowakowska-Zajdel E, Piglowski W, Kopec A, Muc-Wierzgon M. Does human papilloma virus participate in colorectal carcinogenesis? J Biol Regul Homeost Agents. 2012;26(4):757-62.

32. Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z. Risk Factors for Gastric Cancer: A Systematic Review. Asian Pac J Cancer Prev. 2018;19(3):591-603.

33. Sadeghian Z, Bannazadeh Baghi H, Poortahmasebi V, Sadeghi J, Hasani A, Azadi A, et al. Prevalence of Human Papillomavirus Infection in Gastric Cancer in Ardebil Province, Northwest of Iran. virusj. 2022;16(1):28-35. [DOI:10.1155/2022/1099477] [PMID] [PMCID]

34. Roesch-Dietlen F, Cano-Contreras AD, Sánchez-Maza YJ, Espinosa-González JM, Vázquez-Prieto M, Valdés-de la OE, et al. Frequency of human papillomavirus infection in patients with gastrointestinal cancer. Rev Gastroenterol Mex. 2018;83(3):253-8. [DOI:10.1016/j.rgmxen.2017.09.002]

35. Leon ME, Kassa E, Bane A, Gemechu T, Tilahun Y, Endalafer N, et al. prevalence of human papillomavirus and Helicobacter pylori in esophageal and gastroesophageal junction cancer biopsies from a case-control study in Ethiopia. Infect Agent Cancer. 2019;14:19. [DOI:10.1186/s13027-019-0233-x] [PMID] [PMCID]

36. Bozdayi G, Dinc B, Avcikucuk H, Turhan N, Altay-Kocak A, Ozkan S, et al. Is Human Papillomavirus and Helicobacter pylori Related in Gastric Lesions? J Clin Lab. 2019;65(10). [DOI:10.7754/Clin.Lab.2019.181244]

37. Türkay DÖ, Vural Ç, Sayan M, Gürbüz Y. Detection of human papillomavirus in esophageal and gastroesophageal junction tumors: A retrospective study by real-time polymerase chain reaction in an instutional experience from Turkey and review of literature. Pathol Res Pract. 2016;212(2):77-82. [DOI:10.1016/j.prp.2015.10.007] [PMID]

38. Erol D, Bulut Y, Yüce H, Ozercan IH. Investigation of the presence of human papillomavirus DNA in various gastrointestinal carcinoma samples]. Mikrobiyoloji Bul. 2009;43(2):259-68.

39. Ding GC, Ren JL, Chang FB, Li JL, Yuan L, Song X, et al. Human papillomavirus DNA and P16(INK4A) expression in concurrent esophageal and gastric cardia cancers. World J Gastroenterol. 2010;16(46):5901-6. [DOI:10.3748/wjg.v16.i46.5901] [PMID] [PMCID]

40. Bae JM. Human papillomavirus infection and gastric cancer risk: A meta-epidemiological review. World J Virol. 2021;10(5):209. [DOI:10.5501/wjv.v10.i5.209] [PMID] [PMCID]

41. De Souza CRT, Almeida MCA, Khayat AS, da Silva EL, Soares PC, Chaves LC, et al. Association between Helicobacter pylori, Epstein-Barr virus, human papillomavirus and gastric adenocarcinomas. World J Gastroenterol. 2018;24(43):4928. [DOI:10.3748/wjg.v24.i43.4928] [PMID] [PMCID]

42. Xu W-g, Zhang L-j, Lu Z-m, Li J-y, Ke Y, Xu G-w. [Detection of human papillomavirus type 16 E6 mRNA in carcinomas of upper digestive tract]. Zhonghua Yi Xue Za Zhi. 2003;83(21):1910-4.

43. Yuan X-y, Wang M-y, Wang X-y, Chang A-y, Li J. Non-detection of Epstein-Barr virus and Human Papillomavirus in a region of high gastric cancer risk indicates a lack of a role for these viruses in gastric carcinomas. Genet Mol Biol. 2013;36:183-4. [DOI:10.1590/S1415-47572013005000018] [PMID] [PMCID]

44. Kamangar F, Qiao Y-L, Schiller JT, Dawsey SM, Fears T, Sun X-D, et al. Human papillomavirus serology and the risk of esophageal and gastric cancers: Results from a cohort in a high-risk region in China. Int J Cancer. 2006;119(3):579-84. [DOI:10.1002/ijc.21871] [PMID]

45. Fakhraei F, Haghshenas MR, Hosseini V, Rafiei A, Naghshvar F, AlizadehNavaei R. Detection of human papillomavirus DNA in gastric carcinoma specimens in a high-risk region of Iran. Biomed Rep. 2016;5(3):371-5. [DOI:10.3892/br.2016.728] [PMID] [PMCID]

46. Burnett-Hartman AN, Newcomb PA, Mandelson MT, Galloway DA, Madeleine MM, Wurscher MA, et al. No Evidence for Human Papillomavirus in the Etiology of Colorectal Polyps. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2288-97. [DOI:10.1158/1055-9965.EPI-11-0450] [PMID] [PMCID]

47. Deschoolmeester V, Van Marck V, Baay M, Weyn C, Vermeulen P, Van Marck E, et al. Detection of HPV and the role of p16INK4Aoverexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. BMC Cancer. 2010;10(1):117. [DOI:10.1186/1471-2407-10-117] [PMID] [PMCID]